Advanced search

Online first
Review paper
Published online: 2024-07-31

open access

View PDF Download PDF file
Page views 157
Article views/downloads 100
Get Citation

Connect on Social Media

Connect on Social Media

When to perform percutaneous coronary interventions in TAVI patients? Recent advances

Mattia Lunardi1, Francesco Bianchini1, Cristina Aurigemma1, Enrico Romagnoli1, Lazzaro Paraggio1, Emiliano Bianchini2, Andrea Zito2, Carlo Trani12, Francesco Burzotta12
DOI: 10.33963/v.phj.101856
Pubmed: 39140669

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Goel SS, Ige M, Tuzcu EM, et al. Severe aortic stenosis and coronary artery disease-implications for management in the transcatheter aortic valve replacement era: A comprehensive review. J Am Coll Cardiol. 2013; 62(1): 1–10.
    CrossRefPubMed
  2. Walther T, Hamm CW, Schuler G, et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: Prospective data from the GARY registry. J Am Coll Cardiol. 2015; 65(20): 2173–2180.
    CrossRefPubMed
  3. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008; 118(15): e523–e661.
    CrossRefPubMed
  4. Danson E, Hansen P, Sen S, et al. Assessment, treatment, and prognostic implications of CAD in patients undergoing TAVI. Nat Rev Cardiol. 2016; 13(5): 276–285.
    CrossRefPubMed
  5. Reardon MJ, van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017; 376(14): 1321–1331.
    CrossRefPubMed
  6. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016; 374(17): 1609–1620.
    CrossRefPubMed
  7. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019; 380(18): 1695–1705.
    CrossRefPubMed
  8. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019; 380(18): 1706–1715.
    CrossRefPubMed
  9. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364(23): 2187–2198.
    CrossRefPubMed
  10. Kotronias RA, Teitelbaum M, Webb JG, et al. Transcatheter aortic valve implantation with or without percutaneous coronary artery revascularization strategy: a systematic review and meta-analysis. J Am Heart Assoc. 2017; 6(6): 1759–1771.
    CrossRefPubMed
  11. D'Ascenzo F, Verardi R, Visconti M, et al. Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: A meta-analysis of adjusted observational results. EuroIntervention. 2018; 14(11): e1169–e1177.
    CrossRefPubMed
  12. Gautier M, Pepin M, Himbert D, et al. Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes. EuroIntervention. 2011; 7(5): 549–555.
    CrossRefPubMed
  13. Snow TM, Ludman P, Banya W, et al. Management of concomitant coronary artery disease in patients undergoing transcatheter aortic valve implantation: the United Kingdom TAVI Registry. Int J Cardiol. 2015; 199: 253–260.
    CrossRefPubMed
  14. Sankaramangalam K, Banerjee K, Kandregula K, et al. Impact of coronary artery disease on 30-day and 1-year mortality in patients undergoing transcatheter aortic valve replacement: A meta-analysis. J Am Heart Assoc. 2017; 6(10).
    CrossRefPubMed
  15. Griese DP, Reents W, Tóth A, et al. Concomitant coronary intervention is associated with poorer early and late clinical outcomes in selected elderly patients receiving transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2014; 46(1): e1–e7.
    CrossRefPubMed
  16. Chieffo A, Giustino G, Spagnolo P, et al. Routine screening of coronary artery disease with computed tomographic coronary angiography in place of invasive coronary angiography in patients undergoing transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2015; 8(7): e002025.
    CrossRefPubMed
  17. Matsumoto S, Yamada Y, Hashimoto M, et al. CT imaging before transcatheter aortic valve implantation (TAVI) using variable helical pitch scanning and its diagnostic performance for coronary artery disease. Eur Radiol. 2017; 27(5): 1963–1970.
    CrossRefPubMed
  18. van den Boogert TPW, Vendrik J, Claessen BE, et al. CTCA for detection of significant coronary artery disease in routine TAVI work-up : A systematic review and meta-analysis. Neth Heart J. 2018; 26(12): 591–599.
    CrossRefPubMed
  19. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022; 43(7): 561–632.
    CrossRefPubMed
  20. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021; 77(4): 450–500.
    CrossRefPubMed
  21. Di Gioia G, Scarsini R, Strisciuglio T, et al. Correlation between angiographic and physiologic evaluation of coronary artery narrowings in patients with aortic valve stenosis. Am J Cardiol. 2017; 120(1): 106–110.
    CrossRefPubMed
  22. Scarsini R, Pesarini G, Zivelonghi C, et al. Physiologic evaluation of coronary lesions using instantaneous wave-free ratio (iFR) in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention. 2018; 13(13): 1512–1519.
    CrossRefPubMed
  23. Pim AL, Tonino DCJK, Nico HJ. Invasive physiological assessment of coronary disease (FFR). Percutaneous interventional cardiovascular medicine – The PCR-EAPCI Textbook. 2023.
  24. Pesarini G, Scarsini R, Zivelonghi C, et al. Functional assessment of coronary artery disease in patients undergoing transcatheter aortic valve implantation: Influence of pressure overload on the evaluation of lesions severity. Circ Cardiovasc Interv. 2016; 9(11): e004088.
    CrossRefPubMed
  25. Arashi H, Yamaguchi J, Ri T, et al. The impact of tissue Doppler index E/e' ratio on instantaneous wave-free ratio. J Cardiol. 2018; 71(3): 237–243.
    CrossRefPubMed
  26. Scarsini R, Cantone R, Venturi G, et al. Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis. Int J Cardiol. 2019; 292: 162–165.
    CrossRefPubMed
  27. Scarsini R, Pesarini G, Zivelonghi C, et al. Coronary physiology in patients with severe aortic stenosis: Comparison between fractional flow reserve and instantaneous wave-free ratio. Int J Cardiol. 2017; 243: 40–46.
    CrossRefPubMed
  28. Scarsini R, Pesarini G, Lunardi M, et al. Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic stenosis and coronary artery disease undergoing TAVI. Cardiovasc Revasc Med. 2018; 19(3 Pt B): 355–359.
    CrossRefPubMed
  29. Wiegerinck EMA, van de Hoef TP, Rolandi MC, et al. Impact of aortic valve stenosis on coronary hemodynamics and the instantaneous effect of transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2015; 8(8): e002443.
    CrossRefPubMed
  30. Mejía-Rentería H, Nombela-Franco L, Paradis JM, et al. Angiography-based quantitative flow ratio versus fractional flow reserve in patients with coronary artery disease and severe aortic stenosis. EuroIntervention. 2020; 16(4): e285–e292.
    CrossRefPubMed
  31. Fezzi S, Ding D, Scarsini R, et al. Integrated assessment of computational coronary physiology from a single angiographic view in patients undergoing TAVI. Circ Cardiovasc Interv. 2023; 16(10): e013185.
    CrossRefPubMed
  32. Lunardi M, Scarsini R, Venturi G, et al. Physiological versus angiographic guidance for myocardial revascularization in patients undergoing transcatheter aortic valve implantation. J Am Heart Assoc. 2019; 8(22): e012618.
    CrossRefPubMed
  33. Scarsini R, Venturi G, Pighi M, et al. Incomplete functional revascularization is associated with adverse clinical outcomes after transcatheter aortic valve implantation. Cardiovasc Revasc Med. 2022; 42: 47–52.
    CrossRefPubMed
  34. Stortecky S, Buellesfeld L, Wenaweser P, et al. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention. 2011; 7(5): 541–548.
    CrossRefPubMed
  35. Conradi L, Seiffert M, Franzen O, et al. First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention. Clin Res Cardiol. 2011; 100(4): 311–316.
    CrossRefPubMed
  36. van Rosendael PJ, van der Kley F, Kamperidis V, et al. Timing of staged percutaneous coronary intervention before transcatheter aortic valve implantation. Am J Cardiol. 2015; 115(12): 1726–1732.
    CrossRefPubMed
  37. Avvedimento M, Campelo-Parada F, Nombela-Franco L, et al. Procedural characteristics and late outcomes of percutaneous coronary intervention in the workup pre-TAVR. JACC Cardiovasc Interv. 2020; 13(22): 2601–2613.
    CrossRefPubMed
  38. Nijenhuis VJ, Brouwer J, Delewi R, et al. Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med. 2020; 382(18): 1696–1707.
    CrossRefPubMed
  39. Ben-Dor I, Maluenda G, Looser PM, et al. Outcomes of concomitant percutaneous coronary intervention and balloon aortic valvuloplasty. Catheter Cardiovasc Interv. 2013; 82(7): E835–E841.
    CrossRefPubMed
  40. Daniec M, Sorysz D, Dziewierz A, et al. In-hospital and long-term outcomes of percutaneous balloon aortic valvuloplasty with concomitant percutaneous coronary intervention in patients with severe aortic stenosis. J Interv Cardiol. 2018; 31(1): 60–67.
    CrossRefPubMed
  41. Pasic M, Dreysse S, Unbehaun A, et al. Combined elective percutaneous coronary intervention and transapical transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg. 2012; 14(4): 463–468.
    CrossRefPubMed
  42. Blumenstein J, Kim WK, Liebetrau C, et al. Challenges of coronary angiography and intervention in patients previously treated by TAVI. Clin Res Cardiol. 2015; 104(8): 632–639.
    CrossRefPubMed
  43. Allali A, El-Mawardy M, Schwarz B, et al. Incidence, feasibility and outcome of percutaneous coronary intervention after transcatheter aortic valve implantation with a self-expanding prosthesis. Results from a single center experience. Cardiovasc Revasc Med. 2016; 17(6): 391–398.
    CrossRefPubMed
  44. Lunardi M, Venturi G, Del Sole PA, et al. Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation. Int J Cardiol. 2022; 365: 114–122.
    CrossRefPubMed
  45. Ochiai T, Yoon SH, Flint N, et al. Timing and outcomes of percutaneous coronary intervention in patients who underwent transcatheter aortic valve implantation. Am J Cardiol. 2020; 125(9): 1361–1368.
    CrossRefPubMed
  46. Rheude T, Costa G, Ribichini FL, et al. Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2023; 19(7): 589–599.
    CrossRefPubMed
  47. Barbanti M, Costa G, Picci A, et al. Coronary cannulation after transcatheter aortic valve replacement: the RE-ACCESS study. JACC Cardiovasc Interv. 2020; 13(21): 2542–2555.
    CrossRefPubMed
  48. Yudi MB, Sharma SK, Tang GHL, et al. Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement. J Am Coll Cardiol. 2018; 71(12): 1360–1378.
    CrossRefPubMed
  49. Zivelonghi C, Pesarini G, Scarsini R, et al. Coronary catheterization and percutaneous interventions after transcatheter aortic valve implantation. Am J Cardiol. 2017; 120(4): 625–631.
    CrossRefPubMed
  50. Chetcuti S. Percutaneous coronary intervention after self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol. 2016; 68(Suppl 18): B300–B301.
  51. Htun WW, Grines C, Schreiber T. Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic™ self-expandable bioprosthetic valve. Catheter Cardiovasc Interv. 2018; 91(7): 1339–1344.
    CrossRefPubMed
  52. Chakravarty T, Sharma R, Abramowitz Y, et al. Outcomes in patients with transcatheter aortic valve replacement and left main stenting: the TAVR-LM registry. J Am Coll Cardiol. 2016; 67(8): 951–960.
    CrossRefPubMed
  53. Boukantar M, Gallet R, Mouillet G, et al. Coronary procedures after TAVI with the self-expanding aortic bioprosthesis Medtronic Corevalve™, not an easy matter. J Interv Cardiol. 2017; 30(1): 56–62.
    CrossRefPubMed
  54. Tagliari AP, Vicentini L, Zimmermann JM, et al. Transcatheter aortic valve neo-commissure alignment with the Portico system. EuroIntervention. 2021; 17(2): e152–e155.
    CrossRefPubMed
  55. Bieliauskas G, Wong I, Bajoras V, et al. Patient-specific implantation technique to obtain neo-commissural alignment with self-expanding transcatheter aortic valves. JACC Cardiovasc Interv. 2021; 14(19): 2097–2108.
    CrossRefPubMed
  56. Venturi G, Pighi M, Lunardi M, et al. Contrast-induced nephropathy in patients undergoing staged versus concomitant transcatheter aortic valve implantation and coronary procedures. J Am Heart Assoc. 2021; 10(15): e020599.
    CrossRefPubMed
  57. Venturi G, Pighi M, Pesarini G, et al. Contrast-induced acute kidney injury in patients undergoing TAVI compared with coronary interventions. J Am Heart Assoc. 2020; 9(16): e017194.
    CrossRefPubMed
  58. Richter I, Abdel-Wahab M, Desch S, et al. Cerebral embolic protection in patients undergoing transcatheter aortic valve implantation: Recent advances. Kardiol Pol. 2022; 80(6): 644–650.
    CrossRefPubMed
  59. Naganuma T, Kawamoto H, Takagi K, et al. Can we perform rotational atherectomy in patients with severe aortic stenosis? Substudy from the OCEAN TAVI Registry. Cardiovasc Revasc Med. 2017; 18(5): 356–360.
    CrossRefPubMed
  60. Lippmann M, Patel J, Kvapil J, et al. Safety and feasibility of rotational atherectomy in elderly patients with severe aortic stenosis. J Invasive Cardiol. 2017; 29(8): 271–275.
    PubMed
  61. Lunardi M, Pighi M, Venturi G, et al. Short-and-long-term outcomes after coronary rotational atherectomy in patients treated with trans-catheter aortic valve implantation. J Clin Med. 2020; 10(1): 112.
    CrossRefPubMed
  62. Lunardi M, Pesarini G, Scarsini R, et al. Coronary rotational atherectomy in patients treated with transcatheter aortic valve implantation. Structural Heart. 2019; 3(6): 471–477.
    CrossRef
  63. Piccoli A, Lunardi M, Ariotti S, et al. Expanding TAVI options: Elective rotational atherectomy during trans-catheter aortic valve implantation. Cardiovasc Revasc Med. 2015; 16(1): 58–61.
    CrossRefPubMed
  64. Amat-Santos IJ, Blasco-Turrión S, Ferrero V, et al. PCI of bystander coronary artery lesions should be performed before TAVI: Pros and cons. EuroIntervention. 2022; 18(10): 783–785.
    CrossRefPubMed
  65. Novelli L, Jamie G, Regazzoli D, et al. How to predict conduction disturbances after transcatheter aortic valve replacement. Kardiol Pol. 2023; 81(4): 330–337.
    CrossRefPubMed
  66. Bianchini F, Bianchini E, Romagnoli E, et al. Anatomical annulus predictors of new permanent pacemaker implantation risk after balloon-expandable transcatheter aortic valve implantation. Am J Cardiol. 2024; 224: 26–35.
    CrossRefPubMed
  67. Cangemi S, Aurigemma C, Romagnoli E, et al. Management of concomitant coronary artery disease and aortic valve stenosis in the era of transcatheter aortic valve treatment. Mini-invasive Surgery. 2022; 6(3).
    CrossRef

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Copyright © 2023-2024 Via Medica Regulations Cookie policy Privacy Statement Legal Note